LexDanaLexDanabeta
Inventor

Fengjuan ZHAO

Inventor
CN

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,128,049Dosage regimen of paliperidone palmitate extended-release injectable suspension202411,666,573Dosage regimen of paliperidone palmitate extended-release injectable suspension2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to GENEORA PHARMA SHIJIAZHUANG CO LTD (1)· patent assignee history
2023–2024Based in CN· patent location history
2024Patents assigned to LUYE INNOMIND PHARMA SHIJIAZHUANG CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENEORA PHARMA SHIJIAZHUANG CO LTD12023
LUYE INNOMIND PHARMA SHIJIAZHUANG CO LTD12024
Locations
LocationPatentsSpan
CN22023–2024